BUFFALO, NY. — Parkview Health Services, a leading behavioral health pharmacy company, announced that it has been selected as a limited distribution partner by Braeburn Inc. for BRIXADI (buprenorphine) extended-release subcutaneous injections (CIII).
Image from braeburnrx.com
“Parkview is focused on providing the best services available to our clients treating Substance Use Disorder. It is vital that we deliver the best and latest therapies so that providers and caregivers have all the necessary tools to fight the Opioid Epidemic...
...Parkview’s access to the Brixadi Limited Distribution network means our clients can now prescribe Brixadi confidently, knowing they will avoid the many pitfalls that come from dealing with out of state specialty mail order pharmacies,” says Paul O'Leary, CEO, Parkview Health Services.
BRIXADI is an extended-release injection approved by the FDA to treat moderate to severe opioid use disorder in patients who have initiated treatment with a single dose of a transmucosal buprenorphine product or who are already being treated with a transmucosal buprenorphine-containing product. BRIXADI should be used as part of a complete treatment plan that includes counseling and psychosocial support.
BRIXADI offers weekly and monthly dosing options for patients already receiving buprenorphine treatment. It is obtained via a prescription and administered by a healthcare professional in a healthcare setting.
Due to the risk of serious harm resulting from accidental intravenous (IV) administration, BRIXADI has a Boxed Warning and will be made available through a restricted distribution program called the BRIXADI Risk Evaluation and Mitigation Strategy (REMS). Parkview Health Services is certified in this program and complies with all REMS requirements. Information on the BRIXADI REMS program will be available at brixadirems.com.
--
About Parkview Health Services
Parkview Health Services is a pharmacy services provider with corporate headquarters located in Buffalo, NY. Since 1985, they have maintained a commitment to providing quality care and pharmacy services to consumers in assisted living facilities, developmentally disabled residences, mental health clinics, chemical dependency rehabilitation facilities throughout New York State. By combining personalized service with the latest technologies, clients can be assured that their medication needs will be filled efficiently and delivered in a timely fashion. This dramatically reduces the burden of medication fulfillment for both the individual and the facility. Parkview Health Services is accredited by The Compliance Team in Long Term Care, Specialty and Retail pharmacy. Visit parkviewhs.com for more information.
About Braeburn Inc.
Braeburn’s core purpose is to transform the management of Opioid Use Disorder (OUD) to help people begin and sustain their recovery. They are committed to challenging the status quo and championing transformation of the management of OUD. Braeburn partners with the community to create a world where every person with OUD gets the best possible care and opportunity to reach their full potential. Visit braeburnrx.com for more information.
